SALT LAKE CITY, June 11, 2020 /PRNewswire/ -- After years of
hard work, research, and patience, USANA is proud to announce it
has been issued a groundbreaking US patent for its InCelligence
Complex formula. The patent, US Pat. No. 10,632,101, is unique to
the health and wellness industry. It recognizes the InCelligence
Complex formula contains antioxidant compounds that support
endogenous systems associated with optimal lifespans. The patent
was submitted by USANA R&D scientists, Drs. Mark Brown, Jeremy
Tian, and John Cuomo.*
To learn more about this patent and the science behind the
InCelligence Complex formula, please visit USANA's Ask the
Scientists website.
"USANA has always been considered a pioneer in the health and
wellness industry, and this patent separates us even further from
the competition," says Dr. Rob
Sinnott, USANA's chief scientific officer. "The patent
process is not an easy one, with just over 50 percent of all
patents approved each year. For USANA to acquire one with such
serious claims behind it shows how special our InCelligence Complex
formulation truly is. I would like to thank Drs. Brown, Tian, and
Cuomo for all their hard work on this project. What they have
accomplished is a huge game changer for USANA."
USANA's InCelligence Complex is found in its flagship
CellSentials supplement as well as its HealthPak product. The
InCelligence Complex contains antioxidants such as alpha lipoic
acid, resveratrol, curcumin, EGCG, olive fruit extract, rutin,
quercetin, and hesperidin. The patent covers only the US formula of
the InCelligence Complex.
"When we designed the InCelligence Complex, we wanted to create
a formula to help the body protect itself from stress and renew
youthful, normal cellular function," says Dr. Mark Brown, USANA's executive director of
laboratory research. "I'm so proud of the work our team has done on
the formulation, clinical testing, and patent submission for the
InCelligence Complex. You truly don't find this kind of dedication
to the scientific method anywhere else but USANA."*
"Our patent addresses the aging process at the subcellular level
through a process called mitophagy, which may help defend against
oxidative stress and subsequent damage," says Dr. Jeremy Tian, USANA's director of new product
research. "Our formula is the first to achieve this functionality
in a supplement form, and with a clear and specific molecular
mechanism of action."*
*These statements
have not been evaluated by the Food and Drug Administration. This
product is not intended to diagnose, treat, cure, or prevent any
disease.
|
About USANA
USANA (NYSE: USNA) prides itself in providing consumers the highest
quality nutritional products in the world. From its award-winning
supplements to its innovative skincare line, USANA has proven for
more than 25 years why it's a company you can trust. How about
giving us a try? Shop at USANA.com or learn more at
whatsupusana.com.
Media Contact: Ashley Collins
Executive Vice President of Marketing
(801) 954-7629
media(at)us.usana(dot)com
View original content to download
multimedia:http://www.prnewswire.com/news-releases/usana-issued-landmark-patent-for-incelligence-complex-formula-featured-in-their-cellsentials-supplement-301074602.html
SOURCE USANA